When studying brain tumors and what can be done in order to slow their progression, at the very least, certain drugs will be focused on. Some of these may have been utilized to help other conditions in the past while another group of drugs may be entirely unique. Whatever the case may be, it's apparent that some of them will leave greater impacts than others, not only in the medical field but amongst patients as well. Could a potential two-drug combination help to expand results even further?
YottaFire put forth an article that went into detail about a combination of drugs that could come into play in order to stop the progression of brain tumors. A group of mice was focused on, seeing as how each of the test subjects had the condition in question. Following the administration of the drug tandem, it was found that their survival rates had become that much better. To me, this is just one of the reasons as to why this story should be focused on by many organizations, Voices against Brain Cancer included.
Dana-Farber Cancer Institute put together the study and it was determined that a combination of two drugs working together could play positively into the actions of glioblastoma. With this particular tandem, it would be able to focus on two cell signaling pathways. A previous study was done but it was deemed unsuccessful because of how only one pathway was focused on. While this improvement is worthy of note, what is more worthy has got to be a certain abnormality that is typical amongst one-third of glioblastoma patients.
The report talked about the loss of a gene referred to as PTEN. For those who are unaware, PTEN acts as a tumor-suppressing gene. If the PTEN gene is not seen, though, the body is met with a chain reaction that can cause overactive molecular growth signals which, in turn, can cause cells to grow at malignant rates until the activity eventually reaches the brain. With these drugs brought into effect, the gene in question is not replaced but rather the growth caused is blocked.
The human body is one that can go about a number of actions, many of which we are not entirely certain of. What exactly makes said actions come about, one has to wonder? It's clear that not all of them are going to make sense and I am sure that there are many who do not understand the importance behind the PTEN gene. When considering how integral PTEN is in terms of the growth of brain tumors, the focus brought on certain drugs coming together means that much more.
YottaFire put forth an article that went into detail about a combination of drugs that could come into play in order to stop the progression of brain tumors. A group of mice was focused on, seeing as how each of the test subjects had the condition in question. Following the administration of the drug tandem, it was found that their survival rates had become that much better. To me, this is just one of the reasons as to why this story should be focused on by many organizations, Voices against Brain Cancer included.
Dana-Farber Cancer Institute put together the study and it was determined that a combination of two drugs working together could play positively into the actions of glioblastoma. With this particular tandem, it would be able to focus on two cell signaling pathways. A previous study was done but it was deemed unsuccessful because of how only one pathway was focused on. While this improvement is worthy of note, what is more worthy has got to be a certain abnormality that is typical amongst one-third of glioblastoma patients.
The report talked about the loss of a gene referred to as PTEN. For those who are unaware, PTEN acts as a tumor-suppressing gene. If the PTEN gene is not seen, though, the body is met with a chain reaction that can cause overactive molecular growth signals which, in turn, can cause cells to grow at malignant rates until the activity eventually reaches the brain. With these drugs brought into effect, the gene in question is not replaced but rather the growth caused is blocked.
The human body is one that can go about a number of actions, many of which we are not entirely certain of. What exactly makes said actions come about, one has to wonder? It's clear that not all of them are going to make sense and I am sure that there are many who do not understand the importance behind the PTEN gene. When considering how integral PTEN is in terms of the growth of brain tumors, the focus brought on certain drugs coming together means that much more.
About the Author:
If you'd like to uncover more information about brain tumors, take a moment to go to Voices against Brain Cancer
No comments:
Post a Comment